Sanofi India Share Price
3164.70-26.10 (-0.82%)
-38.31% past 1 Year
Sanofi India Limited primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The company has its own manufacturing facility at Goa. It has various independent contract
Corporate filings & documents
Announcements
Kindly refer the attachment
3 days agoKindly refer the attachment
3 days agoKindly refer the attachment
3 weeks agoKindly refer the attachment
3 weeks agoKindly refer the attachment
3 weeks agoKindly refer the attachment
3 weeks agoKindly refer the attachment.
3 weeks agoKindly refer the attachment.
3 weeks agoKindly refer the attachment
4 weeks agoKindly refer the attachment
4 weeks agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment.
1 month agoKindly refer the attachment.
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoKindly refer the attachment
1 month agoSanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve the Unaudited Financial Results for the quarter and half year ended 30th June 2026.
1 month agoSanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve the Unaudited Financial Results for the quarter and half year ended 30th June 2026.
1 month agoPlease find enclosed certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30th June 2026.
1 month agoPlease find enclosed certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30th June 2026.
1 month agoPlease find enclosed disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months agoPlease find enclosed disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months agoKindly refer the attachment
2 months agoKindly refer the attachment
2 months agoPlease find enclosed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months agoPlease find enclosed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months agoPlease find enclosed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months agoPlease find enclosed disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
2 months agoAppointment of Senior Management Personnel of the Company
3 months agoAppointment of Senior Management Personnel of the Company
3 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Oct 2025
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-04-22
Dividend
48.0
2025-11-07
Dividend
75.0
2025-04-25
Dividend
117.0
2024-05-03
Dividend
117.0
2024-03-07
Dividend
50.0
2023-04-28
Dividend
183.0
2022-08-05
Dividend
193.0
2022-04-12
Dividend
490.0
2021-04-19
Dividend
365.0
2020-06-29
Dividend
349.0
2020-04-17
Dividend
349.0
2019-04-26
Dividend
66.0
2019-04-25
Dividend
66.0
2018-08-06
Dividend
18.0
2018-04-26
Dividend
53.0
2017-07-31
Dividend
18.0
2017-04-25
Dividend
50.0
2016-08-04
Dividend
18.0
2016-04-13
Dividend
47.0
2015-07-29
Dividend
18.0
2015-04-16
Dividend
35.0
2014-07-31
Dividend
10.0
2014-04-16
Dividend
35.0
2013-08-05
Dividend
10.0
2013-04-05
Dividend
29.0
2012-08-02
Dividend
4.0
2012-04-10
Dividend
29.0
2011-08-03
Dividend
4.0
2011-03-31
Dividend
51.0
2010-07-26
Dividend
4.0
Company details
Registered office
Sanofi House, C T S No. 117- B L & T Business Park Saki Vihar Road, Powai Mumbai Maharashtra PIN: 400072 Tel No: 022-2803 2000 Fax No: 022-2803 2939 Email: [email protected] Internet: www.sanofiindialtd.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Rahul Bhatnagar, Chairman
Rachid Ayari, Whole Time Director & Chief Financial Officer
Deepak Arora, Managing Director
Renee Amonkar, Whole Time Director & Site Director – Goa
Vaibhav Karandikar, Non Executive Director
Eric Mansion, Non Executive Director
Sudipta Chakraborty, Whole Time Director
Haresh Vala, Company Secretary & Compliance Officer
Rajani Kesari, Non Executive Independent Director
Mahadev Gawade, Whole Time Director & Site Director – Goa
Details
BSE 500674
NSE SANOFI
ISIN INE058A01010